Immunofluorescence results revealed that the isolated CTCs from the advanced breast cancer patient exhibited high expression of CD44 and ALDH1 (Fig. 9C), indicating the conservation of these two stem markers in CTCs from breast cancer patients. Here, CD44 is linked to breast cancer.